Sensitivity analysis for an unobserved moderator in RCT-to-target-population generalization of treatment effects
Not on the map. Why?
Abstract (arXiv)
In the presence of treatment effect heterogeneity, the average treatment effect (ATE) in a randomized controlled trial (RCT) may differ from the average effect of the same treatment if applied to a target population of interest. If all treatment effect moderators are observed in the RCT and in a dataset representing the target population, we can obtain an estimate for the target population ATE by adjusting for the difference in the distribution of the moderators between the two samples. This paper considers sensitivity analyses for two situations: (1) where we cannot adjust for a specific moderator V observed in the RCT because we do not observe it in the target population; and (2) where we are concerned that the treatment effect may be moderated by factors not observed even in the RCT, which we represent as a composite moderator U. In both situations, the outcome is not observed in the target population. For situation (1), we offer three sensitivity analysis methods based on (i) an outcome model, (ii) full weighting adjustment, and (iii) partial weighting combined with an outcome model. For situation (2), we offer two sensitivity analyses based on (iv) a bias formula and (v) partial weighting combined with a bias formula. We apply methods (i) and (iii) to an example where the interest is to generalize from a smoking cessation RCT conducted with participants of alcohol/illicit drug use treatment programs to the target population of people who seek treatment for alcohol/illicit drug use in the US who are also cigarette smokers. In this case a treatment effect moderator is observed in the RCT but not in the target population dataset.
Key facts. Cited by 5 papers in the map (data through 14 Oct 2026). First posted on arXiv 21 Oct 2016.
Builds on
No reference list yet.
Built on by
Citing papers per year: 2021: 1; 2022: 0; 2023: 1; 2024: 3.
5 papers.
- 2021A Review of Generalizability and Transportabilitycited by 37
- 2024Who Are We Missing? A Principled Approach to Characterizing the Underrepresented Populationcited by 6
- 2024Minimax Regret Estimation for Generalizing Heterogeneous Treatment Effects with Multisite Datacited by 5
- 2023Constructing Synthetic Treatment Groups without the Mean Exchangeability Assumptioncited by 0
- 2024Accounting for Missing Covariates in Heterogeneous Treatment Estimationcited by 0
- 2024Minimax Regret Estimation for Generalizing Heterogeneous Treatment Effects with Multisite Data15 Dec 2024
- 2024Accounting for Missing Covariates in Heterogeneous Treatment Estimation21 Oct 2024
- 2024Who Are We Missing? A Principled Approach to Characterizing the Underrepresented Population25 Jan 2024
- 2023Constructing Synthetic Treatment Groups without the Mean Exchangeability Assumption28 Sep 2023
- 2021A Review of Generalizability and Transportability23 Feb 2021